In 2021, antibodies to argonaute proteins 1 and 2 (AGO1 and 2) have been identified in immune diseases of the central and peripheral nervous systems, in particular sensory neuronopathies and limbic encephalitis (147). The gene discussed is AGO1; the disease is immune system disorder.